TOT BIOPHARM International Company Limited (1875.HK)

HKD 2.08

(-0.95%)

Operating Expenses Summary of TOT BIOPHARM International Company Limited

  • TOT BIOPHARM International Company Limited's latest annual operating expenses in 2023 was 607.04 Million CNY , up 45.42% from previous year.
  • TOT BIOPHARM International Company Limited's latest quarterly operating expenses in 2024 Q2 was 343.64 Million CNY , down 0.0% from previous quarter.
  • TOT BIOPHARM International Company Limited reported a annual operating expenses of 409.44 Million CNY in annual operating expenses 2022, up 44.72% from previous year.
  • TOT BIOPHARM International Company Limited reported a annual operating expenses of 282.92 Million CNY in annual operating expenses 2021, down -7.32% from previous year.
  • TOT BIOPHARM International Company Limited reported a quarterly operating expenses of 595.43 Million CNY for 2023 FY, up 45.42% from previous quarter.
  • TOT BIOPHARM International Company Limited reported a quarterly operating expenses of 342.46 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of TOT BIOPHARM International Company Limited (2023 - 2017)

Historical Annual Operating Expenses of TOT BIOPHARM International Company Limited (2023 - 2017)

Year Operating Expenses Operating Expenses Growth
2023 607.04 Million CNY 45.42%
2022 409.44 Million CNY 44.72%
2021 282.92 Million CNY -7.32%
2020 305.26 Million CNY -0.07%
2019 305.48 Million CNY 13.21%
2018 269.84 Million CNY 75.55%
2017 153.71 Million CNY 0.0%

Peer Operating Expenses Comparison of TOT BIOPHARM International Company Limited

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD -86.755%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD 17.884%